| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 苯甘氨酸(元) | 109,646,704.32 | 177,928,162.30 | 96,744,345.15 | 245,321,176.93 | 132,842,626.32 |
| 对羟基苯甘氨酸(元) | 62,952,055.09 | 62,758,991.16 | 27,686,297.70 | 58,883,843.38 | 33,449,262.44 |
| 樟脑磺酸系列产品(元) | 10,424,721.10 | 23,255,331.16 | 15,298,361.36 | 14,693,428.57 | 6,633,887.16 |
| 其他(元) | - | - | 1,231,682.72 | - | - |
| 营业成本(元) | |||||
| 苯甘氨酸(元) | 90,607,858.75 | 143,065,883.30 | 73,584,384.79 | 190,555,025.54 | 104,728,769.84 |
| 对羟基苯甘氨酸(元) | 68,965,581.37 | 72,704,494.84 | 30,280,521.36 | 69,287,559.18 | 40,675,503.41 |
| 樟脑磺酸系列产品(元) | 8,208,116.78 | 17,560,993.47 | 11,626,744.41 | 11,691,858.41 | 5,603,232.98 |
| 其他(元) | - | - | 1,196,994.15 | - | - |
| 毛利(元) | |||||
| 苯甘氨酸(元) | 19,038,845.57 | 34,862,279.00 | 23,159,960.36 | 54,766,151.39 | 28,113,856.48 |
| 对羟基苯甘氨酸(元) | -6,013,526.28 | -9,945,503.68 | -2,594,223.66 | -10,403,715.80 | -7,226,240.97 |
| 樟脑磺酸系列产品(元) | 2,216,604.32 | 5,694,337.69 | 3,671,616.95 | 3,001,570.16 | 1,030,654.18 |
| 其他(元) | - | - | 34,688.57 | - | - |
| 毛利率(%) | |||||
| 苯甘氨酸(%) | 17.36 | 19.59 | 23.94 | 22.32 | 21.16 |
| 对羟基苯甘氨酸(%) | -9.55 | -15.85 | -9.37 | -17.67 | -21.60 |
| 樟脑磺酸系列产品(%) | 21.26 | 24.49 | 24.00 | 20.43 | 15.54 |
| 其他(%) | - | - | 2.82 | - | - |
| 收入构成(%) | |||||
| 苯甘氨酸(%) | 59.91 | 67.41 | 68.63 | 76.93 | 76.82 |
| 对羟基苯甘氨酸(%) | 34.40 | 23.78 | 19.64 | 18.46 | 19.34 |
| 樟脑磺酸系列产品(%) | 5.70 | 8.81 | 10.85 | 4.61 | 3.84 |
| 其他(%) | - | - | 0.87 | - | - |
| 毛利构成(%) | |||||
| 苯甘氨酸(%) | 124.91 | 113.89 | 95.42 | 115.63 | 128.27 |
| 对羟基苯甘氨酸(%) | -39.45 | -32.49 | -10.69 | -21.97 | -32.97 |
| 樟脑磺酸系列产品(%) | 14.54 | 18.60 | 15.13 | 6.34 | 4.70 |
| 其他(%) | - | - | 0.14 | - | - |